5/29/2015
Therapeutic Hypothermia: Where Do We Stand?
Melina Aguinaga-Meza, MD Assistant Professor of Medicine Gill Heart Institute University of Kentucky
Disclosure Information
Melina Aguinaga-Meza, MD “Therapeutic Hypothermia: Where Do We Stand?”
• FINANCIAL DISCLOSURE: – No relevant financial relationship exists • UNLABELED/UNAPPROVED USES DISCLOSURE: – No relevant relationship exists
1 5/29/2015
The Clinical Problem
• Out-of-hospital cardiac arrest (OHCA) is a leading cause of death among adults in the US • Approx. 300,000 OHCA events occur each year in the US • Resuscitation is attempted in 100,000 of these arrests • Less than 40 000 survive to hospital admission
MMWR / July 29, 2011 / Vol. 60 / No. 8
2 5/29/2015
Consequences From Cardiac Arrest
Myocardial Brain injury dysfunction
Post-Cardiac Arrest Syndrome
Systemic ischemia Disorder that + reperfusion caused the cardiac responses arrest
• The effects of this syndrome are severe and pervasive
MMWR / July 29, 2011 / Vol. 60 / No. 8
Survival and Neurological Outcomes after OHCA • Only one third of patients admitted to the hospital survive to hospital discharge • Approx. one out of ten people who experience OHCA survive to hospital discharge • Only 2 out of 3 of them have a good/moderate neurologic recovery
MMWR / July 29, 2011 / Vol. 60 / No. 8: CARES
3 5/29/2015
“Chain of Survival”
• Actions needed to improve chances of survival from out-of-hospital cardiac arrest
Circulation 2010; 122:S676-84
• Try to identify and treat the precipitating causes of the arrest and prevent recurrent arrest. • Identify and treat acute coronary syndromes (ACS) • Optimize mechanical ventilation to minimize lung injury • Reduce the risk of multiorgan injury and support organ function if required • Control body temperature to optimize survival and neurological recovery
4 5/29/2015
Historical Development
History
• 1803 “Russian Method of Resuscitation” consisted of burying the victim of a cardiac arrest in snow hoping for ROSC
Resuscitation 80 (2009) 1335
5 5/29/2015
History
• In 1930s-1940s, hypothermia in cancer patients • In 1950s, induced TH was widely used during head/ spinal cord injuries and cardiac surgery • In 1959, Benson et al., case series of 19 patient post cardiac arrest
Induced Hypothermia Normothermia (30-32 oC) Survived 6 (50%) 1(14%) Died 6 6 Total 12 7
CHEST 2008; 133:1267–1274
History • 1950 -1960s , Deep Hypothermia (<30°C) – Cardiac irritability and ventricular fibrillation – Infections – Coagulopathy • 1960 -1990s, the use of TH decreased • 1990s, animal experiments – Neurological outcome could be improved by using mild to moderate hypothermia (31°C–35°C) rather than deep hypothermia (<30°C) – Fewer and less severe side effects
CHEST 2008; 133:1267–1274
6 5/29/2015
Pathophysiology and Effect of Therapy
Ischemia-Reperfusion Brain Injury • Cascade of destructive events and processes • Begins in minutes and continues for hours/days • Retriggered by new episodes of ischemia
All of these processes are temperature dependent
Crit Care Med 2009; 37[Suppl.]:S186 –S202
7 5/29/2015
Maintains Neuronal Integrity
• Inhibit the “Neuroexcitatory cascade” (Ca++ influx, accumulation of glutamate, and release of glycine) • Blocks Astroglial activation
Front Neuro 2011; 2:1-8 Crit Care Med 2009; 37[Suppl.]:S186 – S202
Avoids Apoptosis
Front Neuro 2011; 2:1-8 Crit Care Med 2009; 37[Suppl.]:S186 – S202
8 5/29/2015
Decreases Brain Metabolism and Oxidative Stress
• Decrease in Cerebral Metabolism, oxygen consumption and glucose • Lowers lactate levels from anaerobic metabolism decreasing cellular acidosis • Blocks release of free radicals • Decreases the concentrations of thromboxane A2
Front Neuro 2011; 2:1-8 Crit Care Med 2009; 37[Suppl.]:S186 – S202
Other Mechanisms of Action
• Decreases Inflammation: – Decreases inflammatory cytokines, leukotrienes, and inflammatory cells function (macrophages) • Decreases cytotoxic edema • Reduces disruption of the blood–brain barrier • Decreases the damage of the endothelial vasculature • Suppresses epileptogenic electrical activity
Front Neuro 2011; 2:1-8 Crit Care Med 2009; 37[Suppl.]:S186 – S202
9 5/29/2015
Clinical Evidence
Fever
10 5/29/2015
Hypothermia-40%
Hyperthermia-26%
Fever ‰ Worse survival
Stroke . 2002;33:1759-1762
• Japan, 1980-1990 • Fever ‰ Worse neurological outcomes • Hyperthermia is an early indicator of brain damage after resuscitation
Intensive Care Med (1991) 17:419-420
11 5/29/2015
• Austria, observational, prospective, 1992-1995 • Witness cardiac arrest with ROSC • Fever ‰ Unfavorable neurologic recovery
Arch Intern Med 2001;161:2007
• Fever is a common complication in patients with various types of neurological injury • Fever is independently associated with an increased risk of adverse outcome
12 5/29/2015
Therapeutic Hypothermia in OHCA with Shockable Rhythm
• Melbourne, Australia • September 1996 and June 1999 • Randomized controlled trial • Patients: – Ventricular Fibrillation – ROSC with persistent coma • Exclusion criteria: – Cardiogenic shock (SBP < 90 mm Hg despite epinephrine infusion) – Other possible causes of coma (drug overdose, head trauma, or cerebrovascular accident)
N Engl J Med 2002;346:557-63
13 5/29/2015
Methods
Hypothermia Normothermia (n=43) (n=34)
• At discharge, outcomes: • Favorable neurologic outcome • Mortality
N Engl J Med 2002;346:557-63
Hypothermia Protocol • Cold packs (ambulance) + ice packs (ED/ICU) • Midazolam + Vecuronium PRN for shivering • Optimal ventilator and hemodynamic support • Thrombolytic for AMI/Heparin for ACS • Lidocaine to prevent recurrent ventricular arrhythmias • Target temperature of 33°C for 12h • Passive rewarming over 8h ROSC ICU Rewarmed
Target temp -2h 0h 33C 12h 18h 24h
N Engl J Med 2002;346:557-63
14 5/29/2015
Characteristics of the Patients
N Engl J Med 2002;346:557-63
Outcomes
Outcome Hypothermia Normothermia p (n=43) (n=34) Good 21 (49%) 9(26%) 0.046 (Neuro) Death 22 (51%) 23(68%) 0.145
• Hypothermia group – OR 5.25 (95% 1.47-18.76; P=0.011) for good outcome
N Engl J Med 2002;346:557-63
15 5/29/2015
Hemodynamics and Adverse Effects
• No significant differences between the two groups with respect to the frequency of adverse events
N Engl J Med 2002;346:557-63
• Europe, March 1996 - January 2001 • Multicenter (9 centers in 5 countries) , randomized, controlled trial • Patients: – Witnessed cardiac arrest – Ventricular Fibrillation or ventricular tachycardia – Collapse - CPR by EMS < 15min. – Collapse - ROSC, < 60 min • Excluded: – Temp < 30 OC, comatose before the cardiac arrest (drugs), response to verbal commands after ROSC, MAP < 60mmHg , persistent hypoxemia, coagulopathy
N Engl J Med 2002;346:549-56
16 5/29/2015
Methods
Hypothermia Normothermia (n=137) (n=138)
• Outcomes at 6 months: – Favorable neurologic outcomes – Overall Mortality – Rate of complications
N Engl J Med 2002;346:549-56
Hypothermia Protocol
• External cooling device (TheraKool) • Sedation with Midazolam and Fentanyl • Pancuronium to prevent shivering • Target temperature of 32°C to 34°C for 24h • Passive rewarming over 8h
Initiation ROSC of cooling Rewarmed
Target temp 32-34°C 0h <2h 8h 28h 36h
N Engl J Med 2002;346:549-56
17 5/29/2015
Temperature Curves
• ROSC-initiation of cooling : 105 min. • ROSC- target temp 8h
N Engl J Med 2002;346:549-56
Characteristics of the Patients
N Engl J Med 2002;346:549-56
18 5/29/2015
Neurologic Outcomes
Cerebral Performance Category V CPC 1 (good recovery) V CPC 2 (moderate disability)
• Therapeutic Mild Hypothermia ‰ Favorable Neurologic Outcome
N Engl J Med 2002;346:549-56
Survival
59%
45% P=0.02
• Therapeutic Mild Hypothermia ‰ Improved Survival
N Engl J Med 2002;346:549-56
19 5/29/2015
Complications
• Complication rate did not differ significantly between the two groups
N Engl J Med 2002;346:549-56
Therapeutic Hypothermia in OHCA with Non-shockable Rhythm
20 5/29/2015
• Brussels, Belgium • Randomized controlled trial • Asystole or pulseless electrical activity (PEA) • Remained unconscious after ROSC • Target temp 34°C for 4h • Helmet device
Resuscitation 51 (2001) 275–281
Outcome Hypothermia Normothermia (n=16) (n=14) Death 13 (81%) 13(92%)
• Lactate and O2 extraction ratio were significantly lower in the hypothermia group
Resuscitation 51 (2001) 275–281
21 5/29/2015
• 19 sites (Europe), 2003-2005, observational, registry • Lower mortality in the hypothermia group in patients with PEA/asystole as first rhythm
Circulation . 2011;123:877-886
• Paris, France, 2000-2009, prospective cohort • No difference in outcomes in patients with PEA/asystole as first rhythm
Circulation . 2011;123:877-886
22 5/29/2015
Therapeutic Hypothermia after In-hospital Cardiac Arrest
• 19 sites (Europe), 2003-2005, observational, registry • No difference in outcomes for patients with in-hospital arrest
Circulation . 2011;123:877-886
23 5/29/2015
Guidelines
Circulation. 2003;108:118-121 Resuscitation 57 (2003) 231/235
24 5/29/2015
2005
Circulation. 2005;000:IV-84-IV-88
Circulation. 2010;122[suppl]:S768 –S786
25 5/29/2015
Circulation. 2010;122[suppl]:S768 –S786
Clinical Use
26 5/29/2015
Phases of Hypothermia Treatment
Induction Maintenance Re-warming Normothermia
Crit Care Med 2009; 37[Suppl.]:S186 –S202
Physiological Aspects of Cooling
“Cold diuresis” “Hypovolemia” “Electrolyte disorders” “Hyperglycemia” “Shivering”
“Prevention of infections” “Continuous EEG: Seizures”
“Hypoglycemia” “Electrolyte disorders: Hyperkalemia”
“Maintain Normothermia”
Crit Care Med 2009; 37[Suppl.]:S186 –S202 J Am Coll Cardiol 2012;59:197–210
27 5/29/2015
Physiologic Effects and Complications
• Shivering • Cardiovascular manifestations • Hyperglycemia • Electrolyte disorders • Bleeding • Alterations in drug metabolism • Risk of Infections
Crit Care Med 2009; 37[Suppl.]:S186 –S202 J Am Coll Cardiol 2012;59:197–210
Cooling Techniques
28 5/29/2015
Conventional Cooling Systems
• Cold saline, crushed ice or ice bags • Easiest and effective way to induce hypothermia • Not so effective in maintaining target temperature
Resuscitation (2007) 73 , 46—53
Surface Cooling Systems • Circulating cold fluid or cold air through blankets/pads wrapped around the patient • Easy to apply and rapid initiation of treatment • Maintenance of temperature may be difficult • Shivering is more common • Complication: Skin burns/irritation
Critical Care (2015) 19:103
29 5/29/2015
Intravascular Cooling Systems • Percutaneously placed central venous catheters • Circulating cool or warm saline in a closed loop through the catheter’s balloon • Less shivering compared to surface devices • Complication: Thrombosis
Critical Care (2015) 19:103
• No difference in outcomes between the groups
Resuscitation 81 (2010) 1117–1122
30 5/29/2015
• Endovascular cooling – Longer time within the target temperature range – Less temperature fluctuation – Better control during rewarming – Less overcooling – Less failure to reach the target temperature
Resuscitation 81 (2010) 1117–1122
Implementation
31 5/29/2015
• Paris, France, 2000-2009 • Prospective cohort
Circulation . 2011;123:877-886
• 243 ICUs in UK • 2002–2009
Anaesthesia, 2010, 65, pages 260–265
32 5/29/2015
National Trends in the Use of Postcardiac Arrest Therapeutic Hypothermia and Hospital Factors Influencing Its Use • Across 2007–2010, in United States
25% 20% 15% 10% 5% 0% 2007 2010 Hospitals using TH 4.60% 22.16% Patients received 0.34% 2.49% TH
Ther Hypothermia Temp Manag. 2015 Mar;5(1):48-54. Epub 2015 Jan
National Trends in the Use of Postcardiac Arrest Therapeutic Hypothermia and Hospital Factors Influencing Its Use
Significant hospital factors associated with TH utilization were: • Large hospitals • Urban location, northeast or west regions • Teaching hospitals • Non-safety net hospitals • Increasing year • Hospitals with higher annual cardiac arrest volume
Ther Hypothermia Temp Manag. 2015 Mar;5(1):48-54. Epub 2015 Jan
33 5/29/2015
Survival During The Last Decade
Survival following OHCA
• In Denmark , Danish Cardiac Arrest Registry • Patients with OHCA , 2001 - 2010
JAMA . 2013;310(13):1377-1384
34 5/29/2015
Survival following OHCA
J Intern Med 2013; 273: 572–583.
• Get with the Guidelines Resuscitation Registry • 374 hospitals in the US, 2000 - 2009
N Engl J Med 2012;367:1912-20
35 5/29/2015
Interventions In Resuscitation Over The Last Decade
• Bystander CPR • Increased use of AED • High quality compressions: compression-only • Good chest compressions and minimal “hands-off time” • Early revascularization (PCI) • Improved post-resuscitation care • Use of ‘track and trigger systems’ to detect patients deterioration (Rapid Response Team) • Mild Therapeutic Hypothermia
N Engl J Med 2012;367:1912-20.
Targeted Temperature Management Post Cardiac Arrest
36 5/29/2015
N Engl J Med 2013;369:2197-206
• Randomized trial, Nov 2010 - Jan 2013 • 36 ICUs in Europe and Australia • Patients: – OHCA, unconscious at presentation to the hospital • Exclusion: – ROSC to screening > 240 minutes(4h) – Unwitnessed arrest with asystole as the initial rhythm – Suspected or known acute intracranial hemorrhage or stroke – Body temperature of less than 30°C
N Engl J Med 2013;369:2197-206
37 5/29/2015
Methods
33°C 36°C (n=473) (n=466)
• Outcomes at 6 months: – Neurologic outcomes – Overall Mortality
N Engl J Med 2013;369:2197-206
TTM Protocol • Method of cooling: – Intravascular cooling catheter (24%) – Surface cooling system (76%) • 33°C vs 36°C for a total of 28h • After 28h gradual rewarming to 37°C (0.5°C/hour) • Maintain < 37.5°C until 72 h after the cardiac arrest
0h 28h 36h Randomization Rewarming
N Engl J Med 2013;369:2197-206
38 5/29/2015
Temperature Curves
• P<0.001 for separation of curves
N Engl J Med 2013;369:2197-206
Characteristics of the Patients
N Engl J Med 2013;369:2197-206
39 5/29/2015
Characteristics of the Patients
N Engl J Med 2013;369:2197-206
Outcomes
• No outcome difference between the two groups
N Engl J Med 2013;369:2197-206
40 5/29/2015
Hazard Ratio of Death, According to Subgroups
The effect of the intervention was consistent across predefined subgroups
N Engl J Med 2013;369:2197-206
Adverse Events
• Hypokalemia was more frequent in the 33°C group • No difference in other adverse event
N Engl J Med 2013;369:2197-206
41 5/29/2015
• Comatose patients after OHCA with initial NSR continue to have a poor prognosis • No effect of TTM at 33 ◦C compared to 36 ◦C in these patients
Resuscitation 89 (2015) 142–148
Conclusions
42 5/29/2015
Normothermia vs. TTM
Normothermia (HACA)
Mortality in Landmark Trials
HACA Bernard TTM (2002) (2002) (2013) Normothermia 55% 68% (37-38°C) 32-34°C 41% 51% 50% 36°C 48% • Fever is independently associated with an increased risk of adverse outcome
43 5/29/2015
Take home messages …..
• In comatose post cardiac arrest patients: – FEVER correlates with worse outcomes and should be avoided – Hypothermia significantly mitigates/prevents destructive processes following ischemia/reperfusion brain injury – Targeted temperature management of 36°C for 28h seems to offer equal benefits as a targeted temperature of 33°C – This intervention should be started within 4h from ROSC
Take home messages ….. • Patients who mostly benefit from this intervention: – Witnessed cardiac arrest – Bystander performed CPR (< 5 min) – Shockable rhythm – ACLS started < 15 min – ROSC < 40 min
44 5/29/2015
Gill Heart Institute
Thanks
45